» Articles » PMID: 27662189

Social Disparities Explain Differences in Hypertension Prevalence, Detection and Control in Colombia

Abstract

Objective: Hypertension is the principal risk factor for cardiovascular diseases. The global Prospective Urban Rural Epidemiology study showed that the levels of awareness, treatment and control of this condition are very low worldwide and show large regional variations related to a country's income index. The aim of the present analysis was to identify associations between sociodemographic, geographic, anthropometric, behavioral and clinical factors and the awareness, treatment and control of hypertension within Colombia - a high-middle income country which participated in the global Prospective Urban Rural Epidemiology study.

Methods And Results: The sample comprised 7485 individuals aged 35-70 years (mean age 50.8 years, 64% women). Mean SBP and DBP were 129.12 ± 21.23 and 80.39 ± 11.81 mmHg, respectively. The overall prevalence of hypertension was 37.5% and was substantially higher amongst participants with the lowest educational level, who had a 25% higher prevalence (<0.001). Hypertension awareness, treatment amongst those aware, and control amongst those treated were 51.9, 77.5 and 37.1%, respectively. The prevalence of hypertension was higher amongst those with a higher BMI (<0.001) or larger waist-hip ratio (<0.001). Being male, younger, a rural resident and having a low level of education was associated with significantly lower hypertension awareness, treatment and control. The use of combination therapy was very low (27.5%) and was significantly lower in rural areas and amongst those with a low income.

Conclusion: Overall Colombia has a high prevalence of hypertension in combination with very low levels of awareness, treatment and control; however, we found large variations within the country that appear to be associated with sociodemographic disparities.

Citing Articles

Community-based model for management and follow-up by non-physician healthcare workers to improve awareness, treatment, and control of hypertension: The COTRACO study protocol.

Lora Mantilla A, Parra Gomez L, Camacho-Lopez P, Otero-Wandurraga J, Novella B, Gonzalez-Medina A Heliyon. 2025; 11(2):e41726.

PMID: 39872457 PMC: 11770540. DOI: 10.1016/j.heliyon.2025.e41726.


Why is there a gap in self-rated health among people with hypertension in Zambia? A decomposition of determinants and rural‒urban differences.

Mweemba C, Mutale W, Masiye F, Hangoma P BMC Public Health. 2024; 24(1):1025.

PMID: 38609942 PMC: 11015612. DOI: 10.1186/s12889-024-18429-6.


The Rationale for Using Fixed-Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review.

Molina de Salazar D, Coca A, Alcocer L, Piskorz D Am J Cardiovasc Drugs. 2024; 24(2):197-209.

PMID: 38489104 PMC: 10972912. DOI: 10.1007/s40256-024-00634-8.


Prevalence of hypertension in adults living at altitude in Latin America and the Caribbean: A systematic review and meta-analysis.

Zila-Velasque J, Soriano-Moreno D, Medina-Ramirez S, Ccami-Bernal F, Castro-Diaz S, Cortez-Soto A PLoS One. 2023; 18(10):e0292111.

PMID: 37824544 PMC: 10569637. DOI: 10.1371/journal.pone.0292111.


General Hospitalization and Intensive Care Unit-Related Factors of COVID-19 Patients in Northeastern Colombia: Baseline Characteristics of a Cohort Study.

Caceres Ramirez C, Lora Mantilla A, Parra Gomez L, Ortegon Vargas V, Posso Paz M, Florez Esparza V Cureus. 2023; 15(8):e43888.

PMID: 37746500 PMC: 10515459. DOI: 10.7759/cureus.43888.